Epizyme's IPO

Epizyme raised a round of funding on May 31, 2013. Investors include Public.

Epizyme is a clinical stage biopharmaceutical company creating personalized therapeutics for patients with genetically defined cancers. Epizyme has built a product platform that the company uses to cr…

Articles about Epizyme's IPO: